ArticleThe Journal of clinical investigation2018

Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer.

Na Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.